HRTX

Heron Therapeutics Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Heron Therapeutics Inc is a biopharmaceutical company focused on the development of pain management and supportive care treatments.

$ 1.22
0.40 %

Heron Therapeutics Inc

$ 1.22
0.40 %
HRTX

Heron Therapeutics Inc is a biopharmaceutical company focused on the development of pain management and supportive care treatments.

Price history of Heron Therapeutics Inc
Price history of Heron Therapeutics Inc

Performance & Momentum

6 Months 16.44 %
1 Year 54.80 %
3 Years 62.62 %
5 Years 94.25 %

Strategic Analysis

Heron Therapeutics Inc • 2026

Heron Therapeutics positions itself as a biopharmaceutical player focused on developing innovative solutions in pain management and supportive care, a niche segment with significant unmet medical need. Its model is based on specializing in targeted products to improve patients’ quality of life, creating differentiation in a highly competitive sector.

Strengths
  • Recognized expertise in developing specific pain management therapies
  • Focus on unmet medical needs in supportive care
  • Presence in the U.S. healthcare market with strong growth potential
Weaknesses
  • Stock performance has deteriorated over the medium and long term
  • No current strong catalysts or recent momentum-generating announcements
Momentum

Momentum appears to be in a prolonged downtrend, reflecting a loss of investor confidence and a lag in recovering performance. This dynamic suggests a risk-taking strategy for investors, to be monitored in connection with future clinical developments or new approvals that could revive the valuation.

Similar stocks to Heron Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone